Treatment of cutaneous metastases of a squamous cell carcinoma of the leg with topical miltefosine

被引:5
作者
Mahieu-Renard, L
Richard, MA
Dales, JP
Buscaylet, S
Lagrassa, S
Grob, JJ
机构
[1] Hop St Marguerite, Serv Dermatol, F-13009 Marseille, France
[2] Hop Nord Marseille, Lab Anatomopathol, Marseille, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2005年 / 132卷 / 04期
关键词
D O I
10.1016/S0151-9638(05)79280-2
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction. Miltefosine (Hexaclecylphosphocholine) is a chemotherapy, which when applied locally, has demonstrated efficacy in the treatment of cutaneous metastases of breast cancer. Case report. A 79 year-old woman developed recurrent in transit cutaneous metastases of a squamous cell carcinoma on her left leg. All lesions completely resolved after topical applications of miltefosine. Tolerance was excellent and the patient remained disease-free 24 months after the end of the treatment. Discussion. Miltefosine, which might prove to be a simple and effective alternative for the usually heavy treatments proposed, warrants further assessment in this context.
引用
收藏
页码:346 / 348
页数:3
相关论文
共 8 条
  • [1] Miltefosine in recurrent cutaneous breast cancer
    Clive, S
    Leonard, RCF
    [J]. LANCET, 1997, 349 (9052) : 621 - 622
  • [2] TOPICAL ADMINISTRATION OF HEXADECYLPHOSPHOCHOLINE IN PATIENTS WITH CUTANEOUS LYMPHOMAS - RESULTS OF A PHASE-I/II STUDY
    DUMMER, R
    KRASOVEC, M
    ROGER, J
    SINDERMANN, H
    BURG, G
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (06) : 963 - 970
  • [3] DUMMER R, 1992, PROG EXP TUMOR RES, V34, P160
  • [4] Hilgard Peter, 1994, Drugs of Today, V30, P13
  • [5] KHAYAT D, 1996, P AN M AM SOC CLIN, V15, P1339
  • [6] Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
    Leonard, R
    Hardy, J
    van Tienhoven, G
    Houston, S
    Simmonds, P
    David, M
    Mansi, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (21) : 4150 - 4159
  • [7] Oral miltefosine for Indian visceral leishmaniasis
    Sundar, S
    Jha, TK
    Thakur, CP
    Engel, J
    Sindermann, H
    Fischer, C
    Junge, K
    Bryceson, A
    Berman, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (22) : 1739 - 1746
  • [8] Wang YZ, 1997, DRUG EXP CLIN RES, V23, P97